SUJAY KANGO
CIK 1336503 · EVP, Chief Commercial Officer · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
24
Lifetime Open-Market Net
-$3.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | Director | — | $82.07 | — | $0 | 2 | 2026-05-22 |
| Lite Strategy, Inc. (MEIP) Delisted | Director | — | $3.20 | — | $0 | 3 | 2023-10-12 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Chief Commercial Officer | 4,197 | $0.04 | $188 | -$95.9K | 5 | 2022-03-31 |
| ACCELERON PHARMA INC (XLRN) Delisted | EVP, Chief Commercial Officer | 0 | $178.75 | $0 | -$3.64M | 14 | 2021-11-22 |
Recent Filings · Page 2 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-04 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | — | -$477.0K | EDGAR |
| 2021-02-02 | ACCELERON PHARMA INC (XLRN) Delisted | Exer (M) | +10,000 | $406.1K | EDGAR |
| 2021-02-02 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +5,409 | $0 | EDGAR |
| 2021-01-06 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −11,357 | -$1.42M | EDGAR |
| 2020-02-14 | ACCELERON PHARMA INC (XLRN) Delisted | Sell (S) | −595 | -$56.0K | EDGAR |
| 2020-01-24 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +6,369 | $0 | EDGAR |
| 2020-01-03 | ACCELERON PHARMA INC (XLRN) Delisted | Sell (S) | −480 | -$24.7K | EDGAR |
| 2019-01-29 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +4,050 | $0 | EDGAR |
| 2018-03-05 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-13 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.